Interferon alfacon-1
Pharmaceutical drug
- L03AB09 (WHO)
- US: ℞-only
- 118390-30-0 Y
- DB00069 N
- none
- 56588OP40D
- DTXSID4040507
Interferon alfacon-1 is a recombinant synthetic type I interferon used for the treatment of hairy cell leukemia, malignant melanoma and AIDS-related Kaposi's sarcoma.[1]
References
- ^ DrugBank DB00069
- v
- t
- e
Immunostimulants (L03)
Cytokines |
| ||||||
---|---|---|---|---|---|---|---|
Other protein / peptide | |||||||
Other |
- beta-glucan
- heterocyclic compound
- hydroxyquinoline
- Mifamurtide
- oligopeptides
- polyribonucleotide
- Polyinosinic:polycytidylic acid
- thiazolidine
- Inosine pranobex
- vaccines
This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e